ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,718Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 1171

$1.49M Total Retail Price of All Prescriptions

Rank: 15 out of 1171

906 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 906 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

18% of this provider’s 906 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 21,692 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
AMLODIPINE BESYLATE 1,400 1,210 1 2
OMEPRAZOLE 945 746 2 5
SIMVASTATIN 917 787 3 1
FUROSEMIDE 850 724 4 6
HYDROCODONE-ACETAMINOPHEN 774 600 S3 5 8
LISINOPRIL 746 609 6 3
METOPROLOL TARTRATE 604 545 7 11
LEVOTHYROXINE SODIUM 517 464 8 4
HYDRALAZINE HCL 510 433 9 60
DONEPEZIL HCL 508 505 10 24
CARVEDILOL 500 392 11 20
DIOVAN 404 363 12 32
WARFARIN SODIUM 395 336 13 12
METFORMIN HCL ER 370 258 14 52
TRAZODONE HCL 365 315 15 37
NAMENDA 360 357 16 42
LOSARTAN POTASSIUM 355 318 17 14
ALLOPURINOL 315 287 18 31
TRAMADOL HCL 308 209 19 18
METOPROLOL SUCCINATE 292 237 20 17
KLOR-CON M20 285 258 21 41
ATORVASTATIN CALCIUM 276 222 22 10
GABAPENTIN 272 223 23 16
POTASSIUM CHLORIDE 252 188 24 19
METFORMIN HCL 250 185 25 7
MIRTAZAPINE 235 229 26 50
CLONIDINE HCL 216 155 27 45
LISINOPRIL-HYDROCHLOROTHIAZIDE 215 160 28 26
LOVASTATIN 213 199 29 36
POLYETHYLENE GLYCOL 3350 213 187 29 72
CLOPIDOGREL 207 180 31 35
PREDNISONE 205 176 32 39
RISPERIDONE 196 189 33 77
PRAVASTATIN SODIUM 174 156 34 13
DIOVAN HCT 174 130 34 65
LEVETIRACETAM 173 114 36 84
OXYBUTYNIN CHLORIDE ER 170 150 37 135
ATENOLOL 158 133 38 15
NIFEDICAL XL 158 125 38 255
PLAVIX 158 137 38 55
NOVOLOG 156 137 41 94
ZOLPIDEM TARTRATE 153 133 42 21
ADVAIR DISKUS 149 119 43 51
CIPROFLOXACIN HCL 143 109 44 61
CITALOPRAM HBR 141 124 45 22
HYDROCHLOROTHIAZIDE 135 84 46 9
BUMETANIDE 134 112 47 93
PANTOPRAZOLE SODIUM 132 106 48 29
ISOSORBIDE MONONITRATE ER 129 105 49 44
TAMSULOSIN HCL 124 117 50 28
INSULIN SYRINGE 124 87 50 71
FINASTERIDE 124 108 50 88
PROAIR HFA 124 55 50 49
JANUVIA 121 88 54 66
SERTRALINE HCL 120 90 55 23
ALBUTEROL SULFATE 115 98 56 102
HALOPERIDOL 115 113 56 176
SPIRIVA 115 87 56 57
LIDODERM 114 108 59 98
LANTUS 114 92 59 46
QUETIAPINE FUMARATE 112 106 61 54
NIFEDIPINE ER 110 88 62 114
SINGULAIR 109 78 63 78
IPRATROPIUM-ALBUTEROL 107 106 64 130
PAROXETINE HCL 96 64 65 62
CRESTOR 92 58 66 27
CYCLOBENZAPRINE HCL 90 45 R 67 67
EXFORGE HCT 88 69 68 387
EXFORGE 88 48 68 208
DILTIAZEM 24HR CD 87 81 70 101
LANTUS SOLOSTAR 84 42 71 90
NOVOLOG MIX 70-30 84 65 71 207
LACTULOSE 83 72 73 108
HUMALOG MIX 75-25 82 48 74 237
ALENDRONATE SODIUM 78 77 75 33
LOSARTAN-HYDROCHLOROTHIAZIDE 78 58 75 40
SPIRONOLACTONE 77 58 77 53
VERAPAMIL ER 77 71 77 91
OXYCODONE-ACETAMINOPHEN 76 49 S2 79 59
LATANOPROST 74 59 80 188
PROMETHAZINE HCL 73 33 R 81 87
BRIMONIDINE TARTRATE 72 72 82 257
AGGRENOX 71 67 83 148
GLIPIZIDE 71 57 83 47
AMLODIPINE BESYLATE-BENAZEPRIL 70 51 85 70
DILTIAZEM ER 69 56 86 221
PEN NEEDLE 69 42 86 122
NAPROXEN 69 59 86 95
TRIAMTERENE-HCTZ 65 49 89 58
ESCITALOPRAM OXALATE 64 63 90 69
BACLOFEN 64 0 90 110
NEXIUM 64 38 90 25
DIGOXIN 63 52 93 68
TRIAMCINOLONE ACETONIDE 62 36 94 133
EXELON 62 52 94 164
CARBIDOPA-LEVODOPA 61 61 96 107
CEPHALEXIN 61 40 96 104
OLANZAPINE 61 53 96 153
HUMULIN 70-30 59 43 99 183
NITROGLYCERIN PATCH 59 59 99 261
NYSTATIN 59 51 99 128
DOXAZOSIN MESYLATE 58 57 102 82
CYMBALTA 58 50 102 64
NITROFURANTOIN MONO-MACRO 57 36 104 210
PHENYTOIN SODIUM EXTENDED 57 35 104 137
CARAFATE 57 57 104 283
RANITIDINE HCL 57 30 104 38
TIZANIDINE HCL 56 0 108 158
QUINAPRIL HCL 55 55 109 156
FAMOTIDINE 55 50 109 75
DILTIAZEM 24HR ER 54 45 111 112
AMIODARONE HCL 53 51 112 192
FENTANYL 53 24 S2 112 89
BENAZEPRIL HCL 52 52 114 83
OXYBUTYNIN CHLORIDE 51 34 115 171
HUMULIN N 51 50 115 190
VENLAFAXINE HCL ER 51 29 115 113
NOVOLIN 70-30 51 36 115 242
LIPITOR 51 33 115 92
FLOVENT HFA 50 40 120 370
NASONEX 50 37 120 218
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 13, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.